Last updated on June 2019

Efficacy Safety and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis


Brief description of study

The primary objective of the study is to assess the efficacy of REGN3500 monotherapy in Atopic dermatitis (AD), as well as understand the dose-response relationship, compared with placebo treatment, in adult patients with moderate-to-severe AD.

Secondary objectives are to:

  • Assess the safety and tolerability of subcutaneous (SC) doses of REGN3500 monotherapy in adult patients with moderate-to-severe AD
  • Assess the Pharmacokinetics (PK) of REGN3500 in adult patients with moderate-to-severe AD
  • Assess the immunogenicity of REGN3500 in adult patients with moderate-to-severe AD

Clinical Study Identifier: NCT03738423

Find a site near you

Start Over

Regeneron Study Site

Birmingham, AL United States
  Connect »

Regeneron Study Site

Phoenix, AZ United States
  Connect »

Regeneron Study Site

Fountain Valley, CA United States
  Connect »

Regeneron Study Site

Fremont, CA United States
  Connect »

Regeneron Study Site

Oceanside, CA United States
  Connect »

Regeneron Study Site

Sacramento, CA United States
  Connect »

Regeneron Study Site

Santa Monica, CA United States
  Connect »

Regeneron Study Site

Jacksonville, FL United States
  Connect »

Regeneron Study Site

Macon, GA United States
  Connect »

Regeneron Study Site

Evansville, IN United States
  Connect »

Regeneron Study Site

Overland Park, KS United States
  Connect »

Regeneron Study Site

Louisville, KY United States
  Connect »

Regeneron Study Site

Saint Joseph, MI United States
  Connect »

Regeneron Study Site

Minneapolis, MN United States
  Connect »

Regeneron Study Site

New York, NY United States
  Connect »

Regeneron Study Site

Wilmington, NC United States
  Connect »

Regeneron Study Site

Cincinnati, OH United States
  Connect »

Regeneron Study Site

Norman, OK United States
  Connect »

Regeneron Study Site

North Charleston, SC United States
  Connect »

Regeneron Study Site

San Antonio, TX United States
  Connect »

Regeneron Study Site

Norfolk, VA United States
  Connect »